Title
Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage
Date Issued
01 February 2004
Access level
open access
Resource Type
journal article
Author(s)
Roseman J.M.
McGwin G.
Uribe A.
Bastian H.M.
Fessler B.J.
Baethge B.A.
Friedman A.W.
Reveille J.D.
Toloza S.
Agee B.S.
Sanchez M.L.
Sowell E.
Johnson B.
Ho K.
Ahn C.
Sandoval R.
Charles J.
Wang L.L.
Hunnicutt S.
Vilá L.M.
Borges W.
Pinilla C.
University of Alabama at Birmingham
Abstract
Objective. To examine the predictors of damage in a multiethnic cohort of systemic lupus erythematosus (SLE) patients with a specific focus on damage at baseline. Patients and methods. SLE patients from a multiethnic US (Hispanic, African-American and Caucasian) cohort (LUMINA: Lupus in Minority populations, Nature versus nurture) were included if they had ≥6 months of follow-up in the cohort. Damage was measured with the Systemic Lupus International Collaborating Clinics (SLICC) Damage Index (SDI). The dependent variable was the change in SDI score between study visits. Predictors were from the preceding visit. Variables known to affect damage accrual in SLE were included in the analyses. Results. Three hundred and fifty-two patients (82 Hispanics, 153 African-Americans and 117 Caucasians) representing 1795 patient visits were included. Previous damage was found to be a significant predictor of subsequent damage accrual (P < 0.0001). Other variables predictive of subsequent damage accrual were disease activity (P < 0.0001), older age (P=0.041) and use of corticosteroids (P=0.0048). Conclusions. Once damage occurs in SLE, further damage is expected to occur. This is more likely to be the case if disease activity persists. These data have clinical implications for the management of SLE patients.
Start page
202
End page
205
Volume
43
Issue
2
Language
English
OCDE Knowledge area
Inmunología
Scopus EID
2-s2.0-10744222430
PubMed ID
Source
Rheumatology
ISSN of the container
14620324
Sponsor(s)
We are grateful to our patients, without whom this study would not have been possible, and to Ella Henderson for her most expert technical assistance in the preparation of this manuscript. This work was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Disorders (grant R01-AR42503) and the General Clinical Research Center [grants M01-RR02558 (UTH-HSC), M01-RR00073 (UTMB) and M01-RR00032 (UAB)].
Sources of information: Directorio de Producción Científica Scopus